Prolia (Denosumab) approved for male osteoporosis (Medical News Today, 24 September 2012)
24 Sept 2012
The US Food and Drug Administration (FDA) has approved the marketing application for Amgen's Prolia (Denosumab) in the treatment of osteoporosis in men.